Improvement of liquid fructose-induced adipose tissue insulin resistance by ginger treatment in rats is associated with suppression of adipose macrophage-related proinflammatory cytokines

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Jianwei ^a   Gao, Huanqing ^a   Ke, Dazhi ^a   Zuo, Guowei ^a   Yang, Yifan ^b   Yamahara, Johji ^c   Li, Yuhao ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Sydney Institute of Health Sciences   (Australia)

^c Pharmafood Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; FATTY ACID; FRUCTOSE; GINGER EXTRACT; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID BLOOD LEVEL; GINGER; HYPERINSULINEMIA; INSULIN RESISTANCE; MACROPHAGE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84874889811     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/590376     Document Type: Article

References (52)

1. Cornier M. A., Dabelea D., Hernandez T. L., The metabolic syndrome. Endocrine Reviews 2008 29 7 777 822
2. Boden G., Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997 46 1 3 10 2-s2.0-0031014830 (Pubitemid 27009941)
3. Attie A. D., Scherer P. E., Adipocyte metabolism and obesity. Journal of Lipid Research 2009 50 S395 S399
4. Gastaldelli A., Cusi K., Pettiti M., Hardies J., Miyazaki Y., Berria R., Buzzigoli E., Sironi A. M., Cersosimo E., Ferrannini E., DeFronzo R. A., Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007 133 2 496 506 2-s2.0-34547514221 10.1053/j.gastro.2007.04.068 (Pubitemid 47187337)
5. Gastaldelli A., Harrison S. A., Belfort-Aguilar R., Hardies L. J., Balas B., Schenker S., Cusi K., Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 2009 50 4 1087 1093 2-s2.0-70350064027 10.1002/hep.23116
6. Neuschwander-Tetri B. A., Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010 52 2 774 788 2-s2.0-77955690182 10.1002/hep.23719
7. Lomonaco R., Ortiz-Lopez C., Orsak B., Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with NAFLD. Hepatology 2012 55 5 1389 1397 10.1002/hep.25539
8. Sharma A. M., Staels B., Review: peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. Journal of Clinical Endocrinology and Metabolism 2007 92 2 386 395 2-s2.0-33847006604 10.1210/jc.2006-1268
9. Bell L. N., Wang J., Muralidharan S., Relationship between adipose tissue insulin resistance and liver histology in NASH: a PIVENS follow-up study. Hepatology 2012 56 4 1311 1318
10. Johnson R. J., Perez-Pozo S. E., Sautin Y. Y., Manitius J., Sanchez-Lozada L. G., Feig D. I., Shafiu M., Segal M., Glassock R. J., Shimada M., Roncal C., Nakagawa T., Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocrine Reviews 2009 30 1 96 116 2-s2.0-60549110854 10.1210/er.2008-0033
11. Stanhope K. L., Schwarz J. M., Keim N. L., Griffen S. C., Bremer A. A., Graham J. L., Hatcher B., Cox C. L., Dyachenko A., Zhang W., McGahan J. P., Seibert A., Krauss R. M., Chiu S., Schaefer E. J., Ai M., Otokozawa S., Nakajima K., Nakano T., Beysen C., Hellerstein M. K., Berglund L., Havel P. J., Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. The Journal of Clinical Investigation 2009 119 5 1322 1334 2-s2.0-66449093225 10.1172/JCI37385
12. Tappy L., Le K. A., Metabolic effects of fructose and the worldwide increase in obesity. Physiological Reviews 2010 90 1 23 46 2-s2.0-75149166672 10.1152/physrev.00019.2009
13. Pollock N. K., Bundy V., Kanto W., Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. Journal of Nutrition 2012 142 2 251 257 10.3945/jn.111.150219
14. Matsuda A., Wang Z., Takahashi S., Tokuda T., Miura N., Hasegawa J., Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism. Life Sciences 2009 84 25-26 903 907 2-s2.0-67349138176 10.1016/j.lfs.2009.04.004
15. Nammi S., Kim M. S., Gavande N. S., Li G. Q., Roufogalis B. D., Regulation of low-density lipoprotein receptor and 3-hydroxy-3- methylglutaryl coenzyme A reductase expression by zingiber officinale in the liver of high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2010 106 5 389 395 2-s2.0-77951073882 10.1111/j.1742-7843.2009.00497.x
16. Gao H., Guan T., Li C., Treatment with ginger ameliorates fructose-induced fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element binding protein-mediated pathway. Evidence-Based Complementary and Alternative Medicine 2012 2012 12 570948 10.1155/2012/570948
17. Rong X., Li Y., Ebihara K., Zhao M., Naowaboot J., Kusakabe T., Kuwahara K., Murray M., Nakao K., Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice. Diabetologia 2010 53 8 1727 1731 2-s2.0-77955512722 10.1007/s00125-010-1744-6
18. Evans R. M., Barish G. D., Wang Y. X., PPARs and the complex journey to obesity. Nature Medicine 2004 10 4 355 361 (Pubitemid 38508511)
19. Barrows B. R., Parks E. J., Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. Journal of Clinical Endocrinology and Metabolism 2006 91 4 1446 1452 2-s2.0-33646035836 10.1210/jc.2005-1709
20. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome. The Lancet 2005 365 9468 1415 1428 2-s2.0-17144380822 10.1016/S0140-6736(05)66378-7 (Pubitemid 40523737)
21. Cusi K., Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clinics in Liver Disease 2009 13 4 545 563 2-s2.0-70349764468 10.1016/j.cld.2009.07.009
22. Vanni E., Bugianesi E., Kotronen A., De Minicis S., Yki-Järvinen H., Svegliati-Baroni G., From the metabolic syndrome to NAFLD or vice versa? Digestive and Liver Disease 2010 42 5 320 330 2-s2.0-77951648486 10.1016/j.dld.2010.01.016
23. Fabbrini E., Sullivan S., Klein S., Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010 51 2 679 689 2-s2.0-75449094816 10.1002/hep.23280
24. Bjorntorp P., Metabolic abnormalities in visceral obesity. Annals of Medicine 1992 24 1 3 5
25. Postic C., Girard J., Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. The Journal of Clinical Investigation 2008 118 3 829 838 2-s2.0-40549135297 10.1172/JCI34275 (Pubitemid 351364588)
26. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes. The Journal of Clinical Investigation 2005 115 5 1111 1119 (Pubitemid 40629025)
27. Ye J., Adipose tissue vascularization: its role in chronic inflammation. Current Diabetes Reports 2011 11 3 203 210
28. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
29. Galic S., Fullerton M. D., Schertzer J. D., AMPK β 1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. The Journal of Clinical Investigation 2011 121 12 4903 4915 10.1172/JCI58577
30. Kamei N., Tobe K., Suzuki R., Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. The Journal of Biological Chemistry 2006 281 36 26602 26614 10.1074/jbc.M601284200 (Pubitemid 44401869)
31. Di Gregorio G. B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L. M., Ranganathan G., Peterson C. A., McGehee R. E., Kern P. A., Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005 54 8 2305 2313 2-s2.0-23644446750 10.2337/diabetes.54.8.2305 (Pubitemid 41134256)
32. Hotamisligil G. S., Peraldi P., Budavari A., Ellis R., White M. F., Spiegelman B. M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF- α-and obesity-induced insulin resistance. Science 1996 271 5249 665 668 2-s2.0-0030061922 (Pubitemid 26052915)
33. Hoene M., Weigert C., The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obesity Reviews 2008 9 1 20 29 2-s2.0-37249074063 10.1111/j.1467-789X.2007.00410.x (Pubitemid 350264626)
34. Nonogaki K., Fuller G. M., Fuentes N. L., Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 1995 136 5 2143 2149
35. Trujillo M. E., Sullivan S., Harten I., Schneider S. H., Greenberg A. S., Fried S. K., Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. Journal of Clinical Endocrinology and Metabolism 2004 89 11 5577 5582 2-s2.0-8744267483 10.1210/jc.2004-0603 (Pubitemid 39518443)
36. Biddinger S. B., Kahn C. R., From mice to men: insights into the insulin resistance syndromes. Annual Review of Physiology 2006 68 123 158 2-s2.0-33645982255 10.1146/annurev.physiol.68.040104.124723
37. Araki E., Lipes M. A., Patti M. E., Bruning J. C., Haag B., Johnson R. S., Kahn C. R., Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994 372 6502 186 190 2-s2.0-0028032895 10.1038/372186a0 (Pubitemid 24347839)
38. Tamemoto H., Kadowaki T., Tobe K., Insulin resistance and growth retardation in mice made with targeted disruption of the IRS-1 gene. Nature 1994 372 6502 182 186 10.1038/372182a0 (Pubitemid 24347838)
39. Benito M., Tissue specificity on insulin action and resistance: past to recent mechanisms. Acta Physiology 2011 201 3 297 312
40. Sell H., Eckel J., Monocyte chemotactic protein-1 and its role in insulin resistance. Current Opinion in Lipidology 2007 18 3 258 262 2-s2.0-34248377344 10.1097/MOL.0b013e3281338546 (Pubitemid 46743048)
41. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K. I., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. The Journal of Clinical Investigation 2006 116 6 1494 1505 2-s2.0-33745216724 10.1172/JCI26498
42. Weisberg S. P., Hunter D., Huber R., CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation 2006 116 1 115 124 10.1172/JCI24335 (Pubitemid 43121796)
43. Ali B. H., Blunden G., Tanira M. O., Nemmar A., Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and Chemical Toxicology 2008 46 2 409 420 2-s2.0-37349127807 10.1016/j.fct.2007.09.085 (Pubitemid 350297543)
44. Tripathi S., Maier K. G., Bruch D., Kittur D. S., Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. Journal of Surgical Research 2007 138 2 209 213 2-s2.0-33847617069 10.1016/j.jss.2006.07.051 (Pubitemid 46365725)
45. Dugasani S., Pichika M. R., Nadarajah V. D., Balijepalli M. K., Tandra S., Korlakunta J. N., Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. Journal of Ethnopharmacology 2010 127 2 515 520 2-s2.0-73749087460 10.1016/j.jep.2009.10. 004
46. Shim S., Kim S., Choi D. S., Kwon Y. B., Kwon J., Anti-inflammatory effects of [6]-shogaol: potential roles of HDAC inhibition and HSP70 induction. Food Chemical Toxicology 2011 49 11 2734 2740
47. Lee H. Y., Park S. H., Lee M., 1-Dehydro-[10]-gingerdione from gingerinhibits IKK β activity for NF- B activation and suppresses NF- B-regulated expression of inflammatory genes. British Journal of Pharmacology 2012 167 1 128 140 10.1111/j.1476-5381.2012.01980.x
48. Kennedy A., Martinez K., Chuang C. C., Lapoint K., Mcintosh M., Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. Journal of Nutrition 2009 139 1 1 4 2-s2.0-58649096801 10.3945/jn.108.098269
49. Talukdar S., Da Y. O., Bandyopadhyay G., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nature Medicine 2012 18 9 1407 1412 10.1038/nm.2885
50. He Z., Jiang T., Wang Z., Levi M., Li J., Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. American Journal of Physiology 2004 287 3 E424 E430 2-s2.0-4143116652 10.1152/ajpendo.00568.2003 (Pubitemid 39095875)
51. Hurtado del Pozo C., Vesperinas-García G., Rubio M. Á., ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity. Biochimica et Biophysica Acta 2011 1811 12 1194 1200 10.1016/j.bbalip.2011.07.016
52. Isa Y., Miyakawa Y., Yanagisawa M., Goto T., Kang M. S., Kawada T., Morimitsu Y., Kubota K., Tsuda T., 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF- α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2008 373 3 429 434 2-s2.0-47249108459 10.1016/j.bbrc.2008.06.046